ESTIMATED
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $2.14 | $2.14 | $2.14 |
Q2 2024 | 0 | $1.83 | $1.83 | $1.83 |
Q3 2024 | 0 | $2.10 | $2.10 | $2.10 |
Bright Minds Biosciences Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Bright Minds Biosciences Inc. has generated $-2 earnings per share over the last year ($-1.98 diluted earnings per share) and currently has a price-to-earnings ratio of -1.22. Bright Minds Biosciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 26th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/16/2024 | Q2 2024 | -$0.13 | $0 | $0 | 02/12/2024 | Q1 2024 | -$0.44 | $0 | $0 | 12/29/2023 | Q4 2023 | -$0.41 | $0 | 08/14/2023 | Q3 2023 | -$0.39 | $0 | 05/15/2023 | Q2 2023 | -$0.56 | $0 | 02/07/2023 | Q1 2023 | -$0.68 | $0 | 12/29/2022 | Q4 2022 | -$1.05 | $0 | 08/12/2022 | Q3 2022 | -$1.12 | $0 | 05/16/2022 | Q2 2022 | -$1.94 | $0 | 12/31/2021 | Q1 2022 | -$2.05 | $0 | 12/29/2021 | Q4 2021 | -$1.21 | $0 | 06/30/2021 | Q3 2021 | -$1.56 | $0 | 03/31/2021 | Q2 2021 | -$1.15 | $0 | 12/31/2020 | Q1 2021 | -$0.67 | $0 | 09/30/2020 | Q4 2020 | -$0.96 | $0 | 06/30/2020 | Q3 2020 | -$0.05 | $0 | 03/31/2020 | Q2 2020 | -$0.01 | $0 | 12/31/2019 | Q1 2020 | -$0.05 | $0 |
---|
A. Bright Minds Biosciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 26th, 2024 based off last year's report dates.
A. The conference call for Bright Minds Biosciences Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Bright Minds Biosciences Inc.'s latest earnings report can be read online.
A. Bright Minds Biosciences Inc. (NASDAQ:DRUG) has a recorded net income of $0. Bright Minds Biosciences Inc. has generated $-1.98 earnings per share over the last four quarters.
A. Bright Minds Biosciences Inc. (NASDAQ:DRUG) has a price-to-earnings ratio of -1.22 and price/earnings-to-growth ratio is -0.02.